Health Economics, Policy and Law

2006 - 2025

From Cambridge University Press
Cambridge University Press, UPH, Shaftesbury Road, Cambridge CB2 8BS UK.
Bibliographic data for series maintained by Kirk Stebbing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 17, issue 4, 2022

Privatising, liberalising and dividing a welfare state without affecting universality? Debunking the myths surrounding the rapid rise of private health insurance in Sweden pp. 367-379

John Lapidus

Does voluntary health insurance reduce the use of and the willingness to finance public health care in Sweden? pp. 380-397

Linn Kullberg, Paula Blomqvist and Ulrika Winblad

How to fairly allocate scarce medical resources? Controversial preferences of healthcare professionals with different personal characteristics pp. 398-415

Micaela Pinho and Alexandra Araújo

Value-based evidence across health care sectors: a push for transparent real-world studies, data, and evidence dissemination pp. 416-427

Remon W. M. van den Broek, Robert J. Matheis, Jennifer L. Bright, Tessa E. Hartog and Eleanor M. Perfetto

If you were a policymaker, which treatment would you disinvest? A participatory value evaluation on public preferences for active disinvestment of health care interventions in the Netherlands pp. 428-443

A. H. Rotteveel, M. S. Lambooij, E. A. B. Over, Jose Ignacio Hernández, A. W. M. Suijkerbuijk, A. T. de Blaeij, G. A. de Wit and N. Mouter

The normative grounds for NICE decision-making: a narrative cross-disciplinary review of empirical studies pp. 444-470

Victoria Charlton

Impact on the NHS and health of the UK's trade and cooperation relationship with the EU, and beyond pp. 471-496

Nick Fahy, Tamara Hervey, Mark Dayan, Mark Flear, Michael J. Galsworthy, Scott Greer, Holly Jarman, Martha McCarey, Martin McKee and Matthew Wood

Volume 17, issue 3, 2022

Physician behaviour, malpractice risk and defensive medicine: an investigation of cesarean deliveries pp. 247-265

David Mushinski, Sammy Zahran and Aanston Frazier

Clinical negligence cases in the English NHS: uncertainty in evidence as a driver of settlement costs and societal outcomes pp. 266-281

Alexander W. Carter, Elias Mossialos, Julian Redhead and Vassilios Papalois

Do patients benefit from legislation regulating step therapy? pp. 282-297

Louis Tharp and Zoe Rothblatt

Past experiences with surprise medical bills drive issue knowledge, concern and attitudes toward federal policy intervention pp. 298-331

Timothy Callaghan, Simon F. Haeder and Steven Sylvester

Does Medicaid expansion influence county health spending? A case of New York counties pp. 332-347

Shihyun Noh and Ji-Hyung Park

Pricing strategies, executive committee power and negotiation leverage in New Zealand's containment of public spending on pharmaceuticals pp. 348-365

Ben Main, Marcell Csanadi and Piotr Ozieranski

Volume 17, issue 2, 2022

Alternative provision of public health care: the role of citizens' satisfaction with public services and the social responsibility of government pp. 121-140

Nissim Cohen, Shlomo Mizrahi and Eran Vigoda-Gadot

Conceptualising equity in the impact evaluation of chronic disease management programmes: a capabilities approach pp. 141-156

Ina Tapager, Kristian Schultz Hansen and Karsten Vrangbæk

Can Asia provide models for tax-based European health systems? A comparative study of Singapore and Sweden pp. 157-174

Richard B. Saltman, Ming-Jui Yeh and Yu Liu

An application of PCA-DEA with the double-bootstrap approach to estimate the technical efficiency of New Zealand District Health Boards pp. 175-199

Antony Andrews

Observations from a small country: mental health policy, services and nursing in Wales pp. 200-211

Ben Hannigan

Resilient managed competition during pandemics: lessons from the Italian experience during COVID-19 pp. 212-219

Joan Costa Font, Rosella Levaggi and Gilberto Turati

Resilient managed competition during pandemics: lessons from the Italian experience pp. 220-223

Germà Bel and Marc Esteve

Answers in search of questions: what does the comparison of COVID19 data among regions in Northern Italy tell us? pp. 224-226

Luke Connelly and Stephen Birch

Health economics and emergence from COVID-19 lockdown: the great big marginal analysis pp. 227-231

Cam Donaldson and Craig Mitton

Ireland's takeover of private hospitals during the COVID-19 pandemic pp. 232-237

Julien Mercille, Brian Turner and Donnacha Seán Lucey

World-beating? Testing Britain's Covid response and tracing the explanation pp. 238-245

Calum Paton

Volume 17, issue 1, 2022

Response to COVID-19: was Italy (un)prepared? pp. 1-13

Iris Bosa, Adriana Castelli, Michele Castelli, Oriana Ciani, Amelia Compagni, Matteo Galizzi, Matteo Garofano, Simone Ghislandi, Margherita Giannoni, Giorgia Marini and Milena Vainieri

France's response to the Covid-19 pandemic: between a rock and a hard place pp. 14-26

Zeynep Or, Coralie Gandré, Isabelle Durand Zaleski and Monika Steffen

Unmasking a health care system: the Dutch policy response to the Covid-19 crisis pp. 27-36

Iris Wallenburg, Jan-Kees Helderman, Patrick Jeurissen and Roland Bal

Belgium's response to the COVID-19 pandemic pp. 37-47

Jeroen Luyten and Erik Schokkaert

Soft law and individual responsibility: a review of the Swedish policy response to COVID-19 pp. 48-61

Ulrika Winblad, Anna-Karin Swenning and Douglas Spangler

United States response to the COVID-19 pandemic, January–November 2020 pp. 62-75

Mathew Alexander, Lynn Unruh, Andriy Koval and William Belanger

The federal government and Canada's COVID-19 responses: from ‘we're ready, we're prepared’ to ‘fires are burning’ pp. 76-94

Sara Allin, Tiffany Fitzpatrick, Gregory P. Marchildon and Amélie Quesnel-Vallée

Australia's Response to COVID-19 pp. 95-106

Anika Stobart and Stephen Duckett

Going hard and early: Aotearoa New Zealand's response to Covid-19 pp. 107-119

Jacqueline Cumming

Alternative provision of public health care: the role of citizens’ satisfaction with public services and the social responsibility of government – ERRATUM pp. 120-120

N. Cohen, S. Mizrahi and E. Vigoda-Gadot

Volume 16, issue 4, 2021

Why we need to face up to the ageing population? pp. 379-382

Anna Dixon

Learning from health system reform trajectories in seven Canadian provinces pp. 383-399

Susan Usher, Jean-Louis Denis, Johanne Préval, Ross Baker, Samia Chreim, Sara Kreindler, Mylaine Breton and Élizabeth Côté-Boileau

Evolution of the determinants of unmet health care needs in a universal health care system: Canada, 2001–2014 pp. 400-423

Ian Allan and Mehdi Ammi

(Re)defining legitimacy in Canadian drug assessment policy? Comparing ideas over time pp. 424-439

Katherine Boothe

Broadening the application of health technology assessment in the Netherlands: a worthwhile destination but not an easy ride? pp. 440-456

Joost J. Enzing, Saskia Knies, Bert Boer and Werner Brouwer

Necessity under construction – societal weighing rationality in the appraisal of health care technologies pp. 457-472

Tineke Kleinhout-Vliek, Antoinette de Bont and Bert Boer

Internal barriers to efficiency: why disinvestments are so difficult. Identifying and addressing internal barriers to disinvestment of health technologies pp. 473-488

Bjørn Hofmann

Organising Research and Development for evidence-informed health care: some universal characteristics and a case study from the UK pp. 489-504

Anthony Culyer and Kalipso Chalkidou

Exorcising the positivist ghost in the priority-setting machine: NICE and the demise of the ‘social value judgement’ pp. 505-511

Victoria Charlton and Albert Weale

Volume 16, issue 3, 2021

Trump v. The ACA pp. 251-255

Michael K. Gusmano, Michael S. Sparer and Lawrence D. Brown

Challenges to sovereign ambitions: forces of convergence and divergence within the global pharmaceutical sector and the UK's withdrawal from the European Union pp. 256-272

John S. F. Wright and Dimitrios Doukas

Cooperation amongst insurers on enhancing quality of care: precondition or substitute for competition? pp. 273-289

Karel C. F. Stolper, Lieke H.H.M. Boonen, Frederik T. Schut and Marco Varkevisser

Assessing the potential impact on health of the UK's future relationship agreement with the EU: analysis of the negotiating positions pp. 290-307

Nick Fahy, Tamara Hervey, Mark Dayan, Mark Flear, Mike Galsworthy, Scott Greer, Holly Jarman and Martin McKee

Tort reform: do details matter? pp. 308-324

Rachel G. Childers

The constitutional economics of the World Health Organization pp. 325-339

Eric C. Ip

Explaining system-level change in welfare governance: the role of policy indeterminacy and concatenations of social mechanisms pp. 340-354

Edoardo Ongaro and Francesco Longo

Mandatory reporting legislation in Canada: improving systems for patient safety? pp. 355-370

C. Milligan, S. Allin, M. Farr, E. Farmanova, A. Peckham, J. Byrd, R. Misfeldt, G. R. Baker and G. P. Marchildon

Expanding health care coverage in Canada: a dramatic shift in the debate pp. 371-377

Gregory P. Marchildon and Carolyn H. Tuohy

Volume 16, issue 2, 2021

The ‘Netflix plus model’: can subscription financing improve access to medicines in low- and middle-income countries? pp. 113-123

Avi Cherla, Natasha Howard and Elias Mossialos

Regulating private medical institutions: a case study of China pp. 124-137

Ziyu Liu

Exploring differences between private and public prices in the English care homes market pp. 138-153

Stephen Allan, Katerina Gousia and Julien Forder

Physicians' attitudes towards accelerated access to medicines pp. 154-169

Jessica Pace, Ian Kerridge, Sallie Pearson and Wendy Lipworth

Double-edged sword of federalism: variation in essential health benefits for mental health and substance use disorder coverage in states pp. 170-182

Charley E. Willison, Phillip M. Singer and Kyle L. Grazier

Explaining health system responses to public reporting of cardiac surgery mortality in England and the USA pp. 183-200

Mark Exworthy, Jon Gabe, Ian Rees Jones and Glenn Smith

State strategies to address medicaid prescription spending: negotiated pricing vs price transparency pp. 201-215

Shihyun Noh, Christian L. Janousek and Ji Hyung Park

Preserving social equity in marketized primary care: strategies in Sweden pp. 216-231

Ulrika Winblad, David Isaksson and Paula Blomqvist

Changes in the balance between formal and informal care supply in England between 2001 and 2011: evidence from census data pp. 232-249

Valentina Zigante, Jose Luis Fernandez and Fernanda Mazzotta

Volume 16, issue 1, 2021

Reinterpreting the health in all policies obligation in Article 168 TFEU: the first step towards making enforcement a realistic prospect pp. 8-22

Oliver Bartlett and Anja Naumann

A tribute to the foot soldiers: European health agencies in the fight against antimicrobial resistance pp. 23-37

Thibaud Deruelle

EU mental health governance and citizen participation: a global governmentality perspective pp. 38-50

Kristin Edquist

Neither protective nor harmonized: the crossborder regulation of medical devices in the EU pp. 51-63

Holly Jarman, Sarah Rozenblum and Tiffany J. Huang

Excessive pricing in the pharmaceutical industry: adding another string to the bow of EU competition law pp. 64-75

Diletta Danieli

The role of EU competition law in health care and the ‘undertaking’ concept pp. 76-89

Johan W. van de Gronden and Mary Guy

Health, federalism and the European Union: lessons from comparative federalism about the European Union pp. 90-103

Scott L. Greer

Transforming health care: the policy and politics of service reconfiguration in the UK's four health systems – CORRIGENDUM pp. 111-111

Ellen Stewart, Scott L. Greer, Angelo Ercia and Peter D. Donnelly